DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Restasis (Cyclosporine Ophthalmic) - Life Threatening Events - Suspected Cause - Side Effect Reports

 
 



Index of reports > Life Threatening Events (2)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Restasis (Cyclosporine Ophthalmic) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Restasis side effects in 63 year old female

Reported by a consumer/non-health professional from United States on 2012-02-15

Patient: 63 year old female, weighing 51.7 kg (113.8 pounds)

Reactions: Nasal Cavity Cancer, Squamous Cell Carcinoma

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Restasis



Possible Restasis side effects in female

Reported by a consumer/non-health professional from United States on 2011-10-24

Patient: female, weighing 81.6 kg (179.6 pounds)

Reactions: Dyspnoea, Chest Discomfort, Chest Pain, Cough

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Restasis
    Dosage: 1 drop/eye 2x daily eye
    Indication: Visual Impairment
    Start date: 2011-03-12
    End date: 2011-09-24

Restasis
    Dosage: 1 drop/eye 2x daily eye
    Indication: Vision Blurred
    Start date: 2011-03-12
    End date: 2011-09-24

Restasis
    Dosage: 1 drop/eye 2x daily eye
    Indication: Visual Impairment
    Start date: 2011-09-19
    End date: 2011-09-23

Restasis
    Dosage: 1 drop/eye 2x daily eye
    Indication: Vision Blurred
    Start date: 2011-09-19
    End date: 2011-09-23

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017